Fasting plasma leptin level is a surrogate measure of insulin sensitivity

Hasan Askari, Gunjan Tykodi, Jianmei Liu, Samuel Dagogo-Jack

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Context: Published studies indicate marked variability in plasma leptin levels among persons with similar body mass index (BMI). We tested the hypothesis that such variations in leptin levels reflect differences in insulin sensitivity. Subjects and Methods: Using euglycemic clamp, we assessed insulin sensitivity (ISI) in 57 nondiabetic adults (36 women, 21 men), whose BMI ranged from 20 to 78 kg/m2. We identified 38 age-matched subjects, stratified by fasting leptin (normal, <15 ng/ml vs. high, ≥15 ng/ml) and BMI (nonobese, <27 kg/m2 vs. overweight/obese, BMI≥27 kg/m 2) and compared ISI across the four strata. Results: Fasting leptin levels correlated with ISI (r = -0.66 in men and -0.60 in women). In a multivariate regression model, leptin emerged as a strong predictor of ISI (r= -0.41, P = 0.0002) after controlling for adiposity, whereas insulin weakened as a predictor (r= -0.32, P = 0.0116). From regression plots of ISI vs. BMI and leptin, a BMI greater than 27 kg/m2 and a leptin level greater than 15 ng/dl strongly predicted decreased ISI. A fasting leptin cutoff of 15 ng/ml for detection of insulin sensitivity has a sensitivity of 72.7%, specificity of 56.3%, and positive predictive value of 69.6%. Overweight/obese subjects with fasting leptin less than 15 ng/ml were 100% more insulin sensitive than control subjects with leptin greater than 15 ng/ml. Conclusions: Insulin sensitivity explains about 40% of the variance in fasting leptin levels. Thus, fasting plasma leptin levels probably serve as an endogenous response to ambient insulin resistance and may provide a surrogate measure of insulin action.

Original languageEnglish (US)
Pages (from-to)3836-3843
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume95
Issue number8
DOIs
StatePublished - Jan 1 2010

Fingerprint

Leptin
Insulin Resistance
Fasting
Insulin
Plasmas
Body Mass Index
Glucose Clamp Technique
Adiposity
Clamping devices
Sensitivity and Specificity

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Fasting plasma leptin level is a surrogate measure of insulin sensitivity. / Askari, Hasan; Tykodi, Gunjan; Liu, Jianmei; Dagogo-Jack, Samuel.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 95, No. 8, 01.01.2010, p. 3836-3843.

Research output: Contribution to journalArticle

@article{0d438ebf2d4e4e33a7a79a0307556971,
title = "Fasting plasma leptin level is a surrogate measure of insulin sensitivity",
abstract = "Context: Published studies indicate marked variability in plasma leptin levels among persons with similar body mass index (BMI). We tested the hypothesis that such variations in leptin levels reflect differences in insulin sensitivity. Subjects and Methods: Using euglycemic clamp, we assessed insulin sensitivity (ISI) in 57 nondiabetic adults (36 women, 21 men), whose BMI ranged from 20 to 78 kg/m2. We identified 38 age-matched subjects, stratified by fasting leptin (normal, <15 ng/ml vs. high, ≥15 ng/ml) and BMI (nonobese, <27 kg/m2 vs. overweight/obese, BMI≥27 kg/m 2) and compared ISI across the four strata. Results: Fasting leptin levels correlated with ISI (r = -0.66 in men and -0.60 in women). In a multivariate regression model, leptin emerged as a strong predictor of ISI (r= -0.41, P = 0.0002) after controlling for adiposity, whereas insulin weakened as a predictor (r= -0.32, P = 0.0116). From regression plots of ISI vs. BMI and leptin, a BMI greater than 27 kg/m2 and a leptin level greater than 15 ng/dl strongly predicted decreased ISI. A fasting leptin cutoff of 15 ng/ml for detection of insulin sensitivity has a sensitivity of 72.7{\%}, specificity of 56.3{\%}, and positive predictive value of 69.6{\%}. Overweight/obese subjects with fasting leptin less than 15 ng/ml were 100{\%} more insulin sensitive than control subjects with leptin greater than 15 ng/ml. Conclusions: Insulin sensitivity explains about 40{\%} of the variance in fasting leptin levels. Thus, fasting plasma leptin levels probably serve as an endogenous response to ambient insulin resistance and may provide a surrogate measure of insulin action.",
author = "Hasan Askari and Gunjan Tykodi and Jianmei Liu and Samuel Dagogo-Jack",
year = "2010",
month = "1",
day = "1",
doi = "10.1210/jc.2010-0296",
language = "English (US)",
volume = "95",
pages = "3836--3843",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "8",

}

TY - JOUR

T1 - Fasting plasma leptin level is a surrogate measure of insulin sensitivity

AU - Askari, Hasan

AU - Tykodi, Gunjan

AU - Liu, Jianmei

AU - Dagogo-Jack, Samuel

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Context: Published studies indicate marked variability in plasma leptin levels among persons with similar body mass index (BMI). We tested the hypothesis that such variations in leptin levels reflect differences in insulin sensitivity. Subjects and Methods: Using euglycemic clamp, we assessed insulin sensitivity (ISI) in 57 nondiabetic adults (36 women, 21 men), whose BMI ranged from 20 to 78 kg/m2. We identified 38 age-matched subjects, stratified by fasting leptin (normal, <15 ng/ml vs. high, ≥15 ng/ml) and BMI (nonobese, <27 kg/m2 vs. overweight/obese, BMI≥27 kg/m 2) and compared ISI across the four strata. Results: Fasting leptin levels correlated with ISI (r = -0.66 in men and -0.60 in women). In a multivariate regression model, leptin emerged as a strong predictor of ISI (r= -0.41, P = 0.0002) after controlling for adiposity, whereas insulin weakened as a predictor (r= -0.32, P = 0.0116). From regression plots of ISI vs. BMI and leptin, a BMI greater than 27 kg/m2 and a leptin level greater than 15 ng/dl strongly predicted decreased ISI. A fasting leptin cutoff of 15 ng/ml for detection of insulin sensitivity has a sensitivity of 72.7%, specificity of 56.3%, and positive predictive value of 69.6%. Overweight/obese subjects with fasting leptin less than 15 ng/ml were 100% more insulin sensitive than control subjects with leptin greater than 15 ng/ml. Conclusions: Insulin sensitivity explains about 40% of the variance in fasting leptin levels. Thus, fasting plasma leptin levels probably serve as an endogenous response to ambient insulin resistance and may provide a surrogate measure of insulin action.

AB - Context: Published studies indicate marked variability in plasma leptin levels among persons with similar body mass index (BMI). We tested the hypothesis that such variations in leptin levels reflect differences in insulin sensitivity. Subjects and Methods: Using euglycemic clamp, we assessed insulin sensitivity (ISI) in 57 nondiabetic adults (36 women, 21 men), whose BMI ranged from 20 to 78 kg/m2. We identified 38 age-matched subjects, stratified by fasting leptin (normal, <15 ng/ml vs. high, ≥15 ng/ml) and BMI (nonobese, <27 kg/m2 vs. overweight/obese, BMI≥27 kg/m 2) and compared ISI across the four strata. Results: Fasting leptin levels correlated with ISI (r = -0.66 in men and -0.60 in women). In a multivariate regression model, leptin emerged as a strong predictor of ISI (r= -0.41, P = 0.0002) after controlling for adiposity, whereas insulin weakened as a predictor (r= -0.32, P = 0.0116). From regression plots of ISI vs. BMI and leptin, a BMI greater than 27 kg/m2 and a leptin level greater than 15 ng/dl strongly predicted decreased ISI. A fasting leptin cutoff of 15 ng/ml for detection of insulin sensitivity has a sensitivity of 72.7%, specificity of 56.3%, and positive predictive value of 69.6%. Overweight/obese subjects with fasting leptin less than 15 ng/ml were 100% more insulin sensitive than control subjects with leptin greater than 15 ng/ml. Conclusions: Insulin sensitivity explains about 40% of the variance in fasting leptin levels. Thus, fasting plasma leptin levels probably serve as an endogenous response to ambient insulin resistance and may provide a surrogate measure of insulin action.

UR - http://www.scopus.com/inward/record.url?scp=77955385339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955385339&partnerID=8YFLogxK

U2 - 10.1210/jc.2010-0296

DO - 10.1210/jc.2010-0296

M3 - Article

C2 - 20484473

AN - SCOPUS:77955385339

VL - 95

SP - 3836

EP - 3843

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 8

ER -